2023
Sex-specific risks for cardiovascular disease across the glycaemic spectrum: a population-based cohort study using the UK Biobank
Rentsch C, Garfield V, Mathur R, Eastwood S, Smeeth L, Chaturvedi N, Bhaskaran K. Sex-specific risks for cardiovascular disease across the glycaemic spectrum: a population-based cohort study using the UK Biobank. The Lancet Regional Health - Europe 2023, 32: 100693. PMID: 37671124, PMCID: PMC10477037, DOI: 10.1016/j.lanepe.2023.100693.Peer-Reviewed Original ResearchCoronary artery diseaseDeep vein thrombosisSex-specific riskCardiovascular diseaseUndiagnosed diabetesGlycaemic spectrumPulmonary embolismExcess riskPopulation-based cohort studyRisk of CVDAge-adjusted HRIncident cardiovascular diseaseBritish Heart FoundationSex-specific associationsUK BiobankWeight reduction strategiesStatin medicationStatin useClinical characteristicsCohort studyComposite outcomeNormal HbA1cVein thrombosisArtery diseaseHeart failure
2021
HbA1c and brain health across the entire glycaemic spectrum
Garfield V, Farmaki A, Eastwood SV, Mathur R, Rentsch CT, Bhaskaran K, Smeeth L, Chaturvedi N. HbA1c and brain health across the entire glycaemic spectrum. Diabetes Obesity And Metabolism 2021, 23: 1140-1149. PMID: 33464682, PMCID: PMC8261644, DOI: 10.1111/dom.14321.Peer-Reviewed Original ResearchConceptsVascular dementiaHippocampal volumeGlycaemic spectrumBrain healthWMH volumeAlzheimer's dementiaAD riskCognitive declineWhite matter hyperintensity volumeIncident vascular dementiaLower WMH volumeHigher WMH volumeGreater hippocampal volumeBrain health outcomesLower hippocampal volumeUK Biobank cohortGlycaemic categoriesKnown diabetesAntihypertensive medicationsHbA1c levelsCause dementiaCertain cardiovascular drugsExcess riskNormoglycaemic individualsHyperintensity volume